Eli Lilly And Co vs United States Natural Gas Fund — how do they compare? Eli Lilly And Co trades at $1,220.51 (market cap $1.08T), while United States Natural Gas Fund trades at $10.19. The key difference: Eli Lilly And Co pays a 0.57% dividend while United States Natural Gas Fund pays none. Which is the better fit depends on your goals.
| LLY | UNG | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | Commodities - Energy |
52-Week High | $1.24K | $16.90 |
52-Week Low | $639.43 | $9.63 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.
LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.
UNG, the United States Natural Gas Fund, trades at $10.23, up 0.89% on the day, with technical indicators showing a bearish bias from moving averages but neutral oscillators. The fund tracks natural gas futures, with recent news highlighting steady prices amid weather-driven demand shifts and geopolitical tensions affecting commodity markets. Key support and resistance cluster around $10, indicating a critical price zone.
The outlook for UNG hinges on natural gas supply-demand dynamics, with EIA forecasting record highs in 2026, but risks include volatility from weather patterns and Middle East conflicts. Investment appeal lies in exposure to energy themes, though the fund's structure as a futures tracker may lead to divergence from spot prices, as noted in comparative analyses with equity-based ETFs like FCG.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →